REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 36 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Advertising Agencies | Office Administrative Services
Full name: Dr.Max 36 S.R.O. Profile Updated: July 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 36 S.R.O. is a company in Slovakia, with a head office in Kosice. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on September 07, 2013. There are currently 10 - 19 (2025) people employed by Dr.Max 36 S.R.O.. There was a net sales revenue increase of 16.55% reported in Dr.Max 36 S.R.O.’s latest financial highlights for 2024. Its total assets grew by 11.86% over the same period. In 2024, Dr.Max 36 S.R.O.’s net profit margin decreased by 0.65%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 36 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 36 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 36 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 36 S.R.O. report to view the information.
Incorporation Date:
September 07, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 36 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.55%▲
Total operating revenue
16.52%▲
Operating profit (EBIT)
-23.73%▼
EBITDA
-22.18%▼
Net Profit (Loss) for the Period
-17.13%▼
Total assets
11.86%▲
Total equity
15.79%▲
Operating Profit Margin (ROS)
-0.89%▼
Net Profit Margin
-0.65%▼
Return on Equity (ROE)
-5.41%▼
Debt to Equity Ratio
-0.38%▼
Quick Ratio
0.02%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Red-Store S.R.O.
 
Pharmnova, S.R.O.
Pharmavit Spol. S R.O.
 
Pharmliptov, S.R.O.
Lekaren Salvator S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo